Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 17 | $9,567,690 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 07 Mar 2025 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Mar 2025 | Sale | 7,326 | 29.98 | 219,633 | D |
| 07 Mar 2025 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Mar 2025 | Sale | 2,674 | 30.62 | 81,878 | D |
| 07 Feb 2025 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Feb 2025 | Sale | 15,000 | 40.58 | 608,700 | D |
| 10 Jan 2025 20:00 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 08 Jan 2025 | Sale | 12,132 | 48.72 | 591,071 | D |
| 10 Jan 2025 20:00 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 08 Jan 2025 | Sale | 2,868 | 49.38 | 141,622 | D |
| 06 Dec 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Dec 2024 | Sale | 13,328 | 46.5 | 619,752 | D |
| 06 Dec 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Dec 2024 | Sale | 1,672 | 47.19 | 78,902 | D |
| 08 Nov 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 06 Nov 2024 | Sale | 14,000 | 59.17 | 828,380 | D |
| 08 Nov 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 06 Nov 2024 | Sale | 1,000 | 59.94 | 59,940 | D |
| 04 Oct 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 02 Oct 2024 | Sale | 30,288 | 56.07 | 1,698,248 | D |
| 04 Oct 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 02 Oct 2024 | Sale | 9,712 | 56.74 | 551,059 | D |
| 06 Sep 2024 20:02 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Sep 2024 | Sale | 14,359 | 48.23 | 692,535 | D |
| 06 Sep 2024 20:02 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 04 Sep 2024 | Sale | 25,641 | 47.28 | 1,212,306 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 07 Aug 2024 | Sale | 100 | 42.17 | 4,217 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 07 Aug 2024 | Sale | 7,667 | 41.52 | 318,334 | D |
| 09 Aug 2024 20:05 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 07 Aug 2024 | Sale | 32,233 | 40.4 | 1,302,213 | D |
| 05 Jul 2024 20:01 | APGE | Apogee Therapeutics Inc | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 05 Jul 2024 | Sale | 15,000 | 37.26 | 558,900 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)